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Abstract 
Obstructive sleep apnea (OSA) is a prevalent and treatable disorder of neurological and medical 
importance that is traditionally  diagnosed through multi-channel laboratory polysomnogra-
phy(PSG). However, OSA testing is increasingly performed with portable home devices using 
limited physiological channels. We tested the hypothesis that single channel respiratory effort 
alone could support automated quantification of apnea and hypopnea events. We developed a 
respiratory event detection algorithm applied to thoracic strain-belt data from patients with 
variable degrees of sleep apnea. We optimized parameters on a training set (n=57) and then tested 
performance on a validation set (n=59). The optimized algorithm correlated significantly with 
manual scoring in the validation set (R
2 = 0.73 for training set, R
2 = 0.55 for validation set; p<0.05). 
For dichotomous classification, the AUC was >0.92 and >0.85 using apnea-hypopnea index cutoff 
values of 5 and 15, respectively. Our findings demonstrate that manually scored AHI values can be 
approximated from thoracic movements alone. This finding has potential applications for auto-
mating laboratory PSG analysis as well as improving the performance of limited channel home 
monitors. 
Key words: algorithm; prediction; respiration, classification; sleep apnea 
Introduction 
Obstructive sleep apnea (OSA) is a common 
disorder with implications for health, well-being, and 
neuro-cognitive performance.  Prevalence estimates 
are typically in the range of 5-25% of adults, depend-
ing on the demographics and definitions of respira-
tory events [1, 2], with higher prevalence occurring 
with certain co-morbidities  [3].  Despite the high 
prevalence and treatable nature of the disorder, many 
individuals with OSA remain un-diagnosed, in part 
due to the cost, inconvenience, and variable availabil-
ity of sleep laboratory testing.  Although laboratory 
polysomnogram (PSG) remains the gold standard for 
diagnosis, portable diagnostic devices are becoming 
increasingly utilized for home testing, which holds 
important promise for reducing the burden of undi-
agnosed OSA.  Although portable devices are often 
assumed to be cost-effective alternatives to lab PSG 
testing, these devices have important limitations and 
formal cost-effectiveness studies have questioned the 
widely held cost-saving assumption [4-8]. The litera-
ture shows that the sensitivity and specificity of 
portable devices are only modest, such that the 
American Academy of Sleep Medicine practice pa-
rameters restricts their use to patients with strong 
pre-test probability (>80%) of moderate or severe 
OSA [9, 10], in other words, home testing should be 
used only to confirm the diagnosis in those with al-
ready high clinical suspicion. However, if improved 
performance of home monitoring devices is accom-
plished, their utility as an alternative to in-lab testing 
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might in the future enjoy more broad applicability. 
This is particularly important given increasing 
cost-burden associated with modern health care de-
livery.  
 Current manual scoring guidelines use multiple 
streams of PSG-derived data to characterize apnea 
and hypopnea events during sleep, including 
measures of effort, airflow, and pulse oximetry. In 
fact, a review of the evidence supporting the use of 
portable monitors, no single-channel devices were 
considered sufficiently accurate for quantifying OSA 
[10].  However, several research reports suggest 
promising results for single-channel approaches to 
OSA detection.  For example, analysis of oximetry, 
nasal pressure, and load cells have shown sensitivity 
and specificity values in the low to mid 80s percent-
age range [11-15]. If the fluctuations in the multiple 
data streams utilized in manual scoring are internally 
correlated, it should be possible to extract substantial 
information from subsets of data. We tested the hy-
pothesis that respiratory effort alone correlated with 
the apnea-hypopnea index (AHI) obtained by manual 
scoring.  Having an easily accessible surrogate for 
respiratory events that conventionally require multi-
ple channels would offer important opportunities to 
improve upon portable OSA testing. Specifically, to 
the extent that a respiratory index such as the AHI 
remains the clinical standard for diagnosing OSA, 
improvements in extracting this information are im-
portant to advance diagnostic accuracy. 
Methods 
Patient population 
 Polysomnography (PSG) data from adult men 
and women who underwent clinical testing in our 
center were selected for analysis.  The Institutional 
Review Board approved retrospective analysis of our 
clinical PSG database without additional consent. The 
PSGs were not selected based on clinical indication, 
although most were conducted for evaluation of sleep 
apnea. Selection was based on AHI and respiratory 
disturbance index (RDI) values to capture a broad 
spectrum of severity. We did not exclude recordings 
based on medication or medical history. This allowed 
a broad spectrum of clinical features to be present and 
preservation of  the potential generality of the find-
ings. The population was chosen to represent typical 
categories of sleep disordered breathing, including: 
none (AHI<5), mild (AHI 5-15), moderate (AHI 
15-30), and severe (AHI>30). For the main analysis, 
we only considered PSGs in which the RDI was simi-
lar to the AHI. Specifically, for the group with "no 
OSA", all had RDI <6 and AHI<5. For patients with 
AHI 5-15, the RDI values were <25 and always within 
15 points of the AHI. For patients with AHI values 
>15, the RDI was always within 20 points. We sepa-
rately selected individuals who showed substantially 
higher RDI than AHI values. For one group (n=10), 
the AHI was <5 while the RDI was >15, and for the 
second group, the AHI was >15, and the RDI was >20 
points above the AHI. 
 The PSGs were randomly divided into two 
groups, ensuring that the spectrum of severity was 
similar in each group. An exhaustive brute-force pa-
rameter search using n=57 diagnostic PSGs was per-
formed on the training set, to maximize the correla-
tion coefficient between the algorithm event index 
and the scored AHI. We used the parameters in the 
training set for validation on the remaining n=59 
testing set.  Independent of the algorithm optimiza-
tion, we manually rated the signal quality of the ab-
dominal and chest belt signals as good, intermediate, 
and high-artifact. We then repeated optimization after 
excluding the high artifact records (n=8 in the training 
set, and n=5 in the validation set). In this optimization 
set, we also restricted analysis to time spent in any 
scored sleep stage (i.e., we excluded scored wake 
time). 
The respiratory event detection algorithm was 
designed to search respiration signal time series data 
for periods of decreased respiration amplitude from 
the abdominal and chest effort belts for a minimum 
duration of time (at least 10 seconds). The raw signals 
from the abdomen and the chest belts were filtered 
and normalized, and the peaks of each inhalation 
were identified. The algorithm then employed an en-
velope tracking function that follows the respiration 
movement peaks, in particular following periods 
when the respiration amplitude falls. This tracking 
function responds with a lag to amplitude decrements 
- that is, it is limited in terms of how fast it “falls”. In 
this way, the decline occurs at a slower rate than the 
normal respiration if there is a decrement in signal, 
such as might occur with apneas and hypopneas. 
Note that even obstructive apneas and hypopneas 
involve ongoing effort, but within the events the am-
plitude of the belts is often seen to be somewhat lower 
amplitude. The tracking function is adaptive, that is, 
for each detected breath, a new amplitude threshold is 
defined, based on the height of the previous peak, 
which accommodates potential drift in breath size or 
belt amplitude changes over a night. If a signal am-
plitude decrement is encountered for a minimum time 
duration, a respiratory event is marked. During the 
optimization routine, three parameters were investi-
gated in a brute-force test of the parameter space: the 
rate of “fall” of the tracking function; the threshold of 
the drop to score an event, and the minimum duration 
of that decrement in amplitude to score an event Int. J. Med. Sci. 2014, Vol. 11 
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(starting at 10 seconds minimum). In each subject, the 
algorithm used either the abdominal belt or the chest 
belt depending on the signal to noise ratio in windows 
of 30 seconds duration.  
 To determine whether algorithm accuracy was 
influenced by factors such as age, sex, BMI, leg 
movements, or sleep efficiency, we conducted non-
parametric correlation analysis with the absolute and 
relative error between the algorithm counts and the 
gold standard technician counts.  
Results 
 Table 1 shows the clinical characteristics of the 
cohort, which included a spectrum of apnea severity. 
The values were similar for the restricted data set in 
which high-artifact individuals were removed, and 
this excluded group was not different in terms of Ta-
ble 1 metrics (not shown). 
Figure 1 shows the relationship between the 
respiratory event index according to the algorithm 
and the technician scored AHI values from overnight 
PSG data. The correlations are shown for the training 
set and testing set in Figures 1A and 1B; both were 
significant to p<0.0001, but the coefficient was smaller 
in the validation set.  We then repeated parameter 
optimization after excluding records judged to have 
excessive signal artifact (see methods) and restricting 
analysis to PSG epochs scored as wake. The improved 
correlation coefficients are shown for the training set 
and testing set in Figures 1C and 1D. 
Table 1: Characteristics of training and testing groups 
  Train set (n=57)  Validation set (n=59) 
Age  50 (18-83)  54 (18-84) 
Sex (% male)  59.6  52.5 
BMI  31 (26-38)  28.0 (25-32) 
TST (min)  367.3 (328.9-420.4)  376.0 (318.5-416.0) 
Sleep latency (min)  6.0 (2.0-10.6)  5.0 (1.0-11.0) 
Efficiency (%)  87.1 (77.1-90.7)  85.4 (74.7-92.2) 
N1 (min)  48.3 (31.6-85.3)  41.0 (25.0-52.7) 
N1 (%)  13.9 (8.5-21.2)  11.9 (6.8-16.9) 
N2 (min)  205.5 (169.5-239.5)  187.5 (152.5-217.0) 
N2 (%)  54.7 (46.7-64.0)  52.2 (45.9-59.5) 
N3 (min)  45.3 (18.3-73.6)  60.0 (28.5-89.0) 
N3 (%)  12.2 (5.6-19.6)  16.5 (7.0-25.1) 
REM (min)  53.8 (27.5-76.5)  56.5 (34.5-82.0) 
REM (%)  14.6 (9.3-20.2)  15.4 (10.9-21.6) 
REM Lat (min)  122.3 (72.4-225.0)  112.5 (74.0-174.0) 
PLMS (#/hr)  17 (10.6-36.8)  11.8 (1.2-29.1) 
AHI (#/hr)  11.7 (3.1-24.3)  12.3 (3.1-22.1) 
RDI (#/hr)  15.4 (4.5-33.0)  17.9 (6.7-32.9) 
# central events  2.0 (0.0-12.8)  2.0 (1.0-7.0) 
Values are median with 25-75% range (except sex, which is given as % only, and 
age, which is given as a min-max range).   
 
 
Figure 1. Correlation of algorithm with technician scored PSG AHI values. Panel A shows the scatter plot of the algorithm index against the 
technician-scored index for subjects in the training set. The best fit line (solid line) and 95% confidence intervals (dotted lines) are given, with the resulting 
R
2 value. Panel B shows the scatter plot and best fit line with confidence intervals for the validation set. The scatter plots and best fit lines are also shown 
after excluding high-artifact individuals and restricting analysis to scored sleep during the PSG, for the training set (panel C) and testing set (panel D).  Int. J. Med. Sci. 2014, Vol. 11 
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Figure 2. Bland-Altman plots. The difference between the algorithm 
AHI and the PSG AHI (y-axis) is plotted against the average of these two 
metrics in Bland Altman plots performed using the full data set (panel A), 
and the set restricted to scored-sleep and excluding high-artifact records 
(panel B).  
 
Bland-Altman analysis was performed for vali-
dation set performance based on the full data set 
(Figure 2A) and the restricted data set of scored sleep 
in good quality records (Figure 2B). This analysis re-
vealed that the algorithm tended to over-estimate the 
respiratory event rate for low AHI cases (by PSG cri-
teria) and tended to under-estimate the event rate as 
the PSG-scored AHI value increased.  
We next conducted receiver operator character-
istic (ROC) analysis on the validation set data, by 
varying the algorithm score cutoff value for ap-
nea-or-not classification, to determine the sensitivity, 
specificity, and area under the curve (AUC) for cate-
gorizing each case according to binary clinical cutoff 
values of PSG AHI =5 (Figure 3A and 3B) or PSG AHI 
=15 (Figure 3C and 3D). In each case, the analysis was 
performed when all subjects were included versus 
excluding high-artifact records and scored wake time. 
The AUC values using a cutoff of PSG AHI =5 cutoff 
were similar for the whole set and for the restricted 
data set (0.93 versus 0.95, respectively) (Figure 3A and 
3B). At a threshold respiratory event rate value of 7.5 
for the algorithm, the sensitivity was 88.4%, and the 
specificity was 81.3%. This yields a positive likelihood 
ratio (LR(+)) of 4.7, and LR(-) of 0.14. Considering the 
restricted data set, for a cutoff of AHI =5, a threshold 
respiratory event rate value of 7.5 for the algorithm 
improved the sensitivity to 90.2% and the specificity 
to 84.6%. The LR(+) and LR(-) values were 5.9 and 0.12, 
respectively. The AUC values for a cutoff of AHI =15 
indicated decreased accuracy in the validation set 
including all subjects or the restricted set (Figure 3C 
and 3D). Here, the sensitivity and specificity values 
were ≤80% in each case. 
We also investigated algorithm accuracy (opti-
mized as above) when applied to two groups of pa-
tients with large disparities between the RDI and AHI 
values, one in which the AHI values were <5 while 
the RDI values were >15, and another in which AHI 
values were greater than 15 and the RDI exceeded the 
AHI by at least 20. In the former group, the correlation 
coefficient was 0.42 (p<0.05) using parameters opti-
mized for the restricted data set, and was 
non-significant using parameters optimized for the 
entire data set (data not shown). In the latter group, 
the correlation coefficient was 0.46 (p<0.001) for the 
restricted set, and 0.34 (p<0.006) for the full set (data 
not shown).  Thus, performance is sensitive to the 
types of respiratory events, such that the presence of 
excess RERAs was associated with reduced perfor-
mance.  That the algorithm could score individuals 
closer to the AHI in some cases and closer to the RDI 
in other cases raises the possibility that RERAs are 
heterogeneous and may include a subset that resem-
ble apneas and hypopneas in terms of respiratory 
effort. 
 Finally, we performed correlation analysis to 
determine whether the accuracy of respiratory event 
rate values depended on certain clinical and PSG 
characteristics. Table 2 shows the correlation coeffi-
cient values for the accuracy defined as the absolute 
difference between PSG AHI and the algorithm score. 
Scoring accuracy did not vary with age, sex, BMI, or 
sleep architecture parameters.  
Table 2: Correlations with algorithm index accuracy 
Age  0.32 
Sex (% male)  0.23 
BMI  -0.18 
TST (min)  -0.05 
Efficiency (%)  0.05 
N1 (min)  0.24 
N1 (%)  0.26 
N2 (min)  0.05 
N2 (%)  0.05 
N3 (min)  -0.28 
N3 (%)  -0.27 
REM (min)  0.15 
REM (%)  0.15 
REM Lat (min)  -0.23 
PLMS (#/hr)  0.21 
# central events  0.26 
Pearson r-values for the restricted data set (excluding scored wake, and excluding 
high-artifact records). None were significant at p<0.05 Int. J. Med. Sci. 2014, Vol. 11 
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Figure 3. Algorithm performance for sleep apnea severity categorization. The area under the curve (AUC) is shown for dichotomous sleep 
apnea categorization using a cutoff AHI = 5 when applied to the whole data set (panel A) versus the filtered set (panel B). Below each AUC curve is the 
corresponding confusion matrix of the optimal performance, including sensitivity, specificity, and predictive value. Categories determined by PSG AHI are 
in the columns, while the cutoff values used for the algorithm to yield these performance indices are in the rows. Similar plots are shown using a cutoff value 
for PSG AHI =15 (panels C and D). 
 
Discussion 
The respiratory events that occur in sleep apnea 
are categorized into conventional classes, such as ob-
structive versus central, or apnea versus hypopnea 
versus RERA, based on visual interpretation of a 
combination of physiological signals. We tested the 
hypothesis that the AHI can be quantified using only 
the respiratory effort signal, and found that respira-
tory effort signal contains sufficient information to 
quantify sleep apnea in an automated manner. Algo-
rithm performance correlated well with manually 
scored AHI values obtained during routine diagnostic 
laboratory PSG, and the algorithm performed well 
across a range of sleep apnea severity. These results 
have implications both for automated event counting 
to facilitate human PSG scoring, and for improving 
the performance of home sleep monitoring devices 
that capture respiratory movements.  Improving au-
tomated apnea detection has implications for im-
proved screening for undiagnosed OSA using home 
monitoring devices, which are currently limited in 
their evidence basis.  
Clinical implications 
 Under modern definitions, signals of respiratory 
effort, air flow, and oxygen saturation are involved in Int. J. Med. Sci. 2014, Vol. 11 
 
http://www.medsci.org 
801 
scoring apneas and hypopneas, and also characteriz-
ing respiratory events as obstructive versus mixed or 
central.  These distinctions continue to play an im-
portant role in clinical sleep medicine at diagnosis as 
well  as during titration and treatment monitoring. 
Limited channel portable monitoring is increasingly 
available for OSA diagnostics [9, 10]. These devices 
typically acquire respiration effort, airflow, and oxy-
gen saturation.  There is only one portable monitor 
approved by Medicare in the United States that does 
not involve a measure of airflow and respiration effort 
(the WatchPAT from Itamar). None of the approved 
devices utilizes a single channel of physiology [9].  
 The standard for accuracy of a portable apnea 
monitor proposed by the AASM  [9] was modest: a 
positive likelihood ratio of 5, which can be obtained 
for example with a device showing 84% sensitivity 
and 84% specificity. An LR(+) of 5 can also be achieved 
with other combinations, for example sensitivity as 
low as 50% or 25% if specificity were 90% or 95%. 
However, the AASM guidelines required the sensi-
tivity to be at least 82.5% to combine with specificity 
in this to yield the LR minimum of 5 (that is, the 
minimum specificity would be 83.5%).  
 Our study demonstrates that changes in respir-
atory effort encode sufficient information regarding 
the respiratory pauses of sleep disordered breathing 
to allow for automated detection of apneas and hy-
popneas.  Distinguishing between RERAs (contrib-
uting only to the RDI) and apneas/hypopneas (con-
tributing to the AHI and the RDI) is primarily a con-
cern when the two values differed substantially, es-
pecially when the AHI is in the normal range. In this 
setting, our algorithm performance was sub-optimal. 
However, when both the RDI and AHI values were 
greater than 5, accuracy was preserved in detection of 
OSA (AHI>5). In other words, although the accuracy 
was poor from a correlation coefficient standpoint, the 
algorithm was accurate in dichotomous classification 
of OSA in that setting, without any false negatives.  
Evidence for the diagnostic utility of 
single-channel physiology algorithms 
Several groups have investigated single channel 
approaches to OSA detection. In a cohort of patients 
with major cardiovascular disease and/or risk factors, 
two thirds of whom had AHI >15 on PSG, pulse oxi-
metry signals showed high correlation with the AHI 
(>0.90), including accurate detection of Cheyne-Stokes 
respiration [13]. However, not all studies of oximetry 
have been positive  [16], including important differ-
ences between automated desaturation indices com-
pared to expert-reviewed signals  [17].  In addition, 
inter-device measurement variance is a notable source 
of uncertainty when considering validation studies 
using oximetry [18].  
Single lead ECG has been reported for detection 
of obstructive events using machine learning applied 
to data after excluding artifacts  [19], as well as for 
distinguishing central from obstructive patterns of 
sleep apnea events [20]. Nasal pressure alone showed 
high detection accuracy across a range of OSA sever-
ity observed in a clinical population at high risk for 
OSA [11]. However, other studies showed that accu-
racy of this approach was lower in patients with dia-
betes [21]. In addition to using single channel analysis 
of routinely acquired signals, other methods for re-
cording sleep disordered breathing have been pro-
posed, including audio  [22, 23], radio frequency 
analysis [24, 25], mattress sensors [26], and load cells 
placed under the bed [15].  
Conclusion 
 The  AHI remains a commonly used clinical 
metric of OSA presence and severity. Portable moni-
tor measurements of the AHI, or a surrogate for it, 
hold important promise for improving the diagnostic 
utility of limited channel testing.  Respiratory effort 
signals are easily accessible markers of respiratory 
pauses that would correlate with standard metrics 
that consider airflow, oxygenation, and EEG changes. 
Although clinical scoring of sleep apnea during PSG 
testing combines oximetry and EEG arousal, it is evi-
dent from this study that much of the information 
contained in these multi-channel scoring techniques, 
particularly information relevant for determination of 
apnea severity, is carried by respiratory effort in iso-
lation. This approach has implications for automated 
analysis of data acquired in the laboratory setting, as 
well as potentially improved the diagnostic yield of 
home devices that employ respiratory effort.  Im-
proved screening technology is especially important 
for neurological populations, in whom undiagnosed 
OSA is prevalent, such as stroke [27], cognitive im-
pairment [28], degenerative disorders [29], and epi-
lepsy [30]. Treatment of this reversible cause of sleep 
disturbance holds promise for improving neurologi-
cal function. 
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